Patient Zone

Children with no COVID-19 symptoms may shed virus for weeks

New research suggests that children can shed SARS-CoV-2, the virus that causes COVID-19, even if they never develop symptoms or…

5 years ago

Product Recall: Amiodarone HCl Injection, USP and Tranexamic Acid Injection, USP

Mylan Initiates Voluntary Nationwide Recall of Four Lots of Amiodarone HCl Injection, USP and Tranexamic Acid Injection, USP Due to…

5 years ago

Colchicine Shows 48% Reduction in Future Cardio Issues for Heart Attack Victims

Early, in-hospital treatment with colchicine reduces the odds of future cardiovascular problems by 48% in people who have just survived…

5 years ago

The Inept “Puppy Syndrome” and a COVID-19 Suicide Effect

It’s time we explore what’s going on and why kids may want to commit suicide or will commit suicide, especially…

5 years ago

10 Coping Strategies to Help You Deal With Chronic Pain

While there is no miracle drug or solution that can take away your pain completely, there are some strategies that…

5 years ago

Egg Freezing Fights Fertility’s Biological Clock

No one should tell a woman when or if she should have a baby. That decision is up to her,…

5 years ago

Is Sex Safe During the Covid-19 pandemic?

If you are your partner are self-isolating during the Covid-19 pandemic there is no evidence to suggest you should avoid…

5 years ago

INOVIO’s COVID-19 Vaccine Shows Durable Antibody and T Cell Responses

INOVIO's COVID-19 DNA Vaccine INO-4800 Provides Protection with Memory Immune Responses In Non-Human Primates Challenged with SARS-CoV-2 Virus

5 years ago

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and…

5 years ago

Hepion Pharmaceuticals’ CRV431 Demonstrates Efficacy in Kidney Fibrosis

CRV431 has exerted antifibrotic activity in a number of in vitro and in vivo studies conducted by independent research laboratories

5 years ago

This website uses cookies. Your continued use of the site is subject to the acceptance of these cookies. Please refer to our Privacy Policy for more information.

Read More